Stock listing
NASDAQ:AMLN Amylin Pharmaceuticals LLC Stock
Follow Amylin Pharmaceuticals LLC into a list and get an email when it puts out news.
Last close · NASDAQ:AMLN
$30.98 USD
Close on Aug 8, 2012 · No longer trades
- Lowest – highest close
- $0.313 – $51.43 USDSince Dec 31, 1997 · lowest Oct 23, 1998 · highest Aug 9, 2007
Delisted NASDAQ:AMLN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AMLN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Amylin Pharmaceuticals LLC on 6ix
- Decks
- 7 decks · latest Nov 8, 2011
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (November 2011) | Merger or acquisition | 29 slides | Nov 8, 2011 |
| Proxy Contest (May 2009) | Proxy contest | 8 slides | May 14, 2009 |
| Proxy Contest (May 2009) | Proxy contest | 7 slides | May 11, 2009 |
| Proxy Contest (May 2009) | Proxy contest | 33 slides | May 5, 2009 |
| Proxy Contest (May 2009) | Proxy contest | 43 slides | May 5, 2009 |
| Q1 2009 Earnings Presentation | Earnings | 14 slides | Apr 16, 2009 |
| Cowen and Company 29th Annual Health Care Conference 2009 | Conference | 15 slides | Mar 17, 2009 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Vaughn D Bryson Other companies: Pharmaceutical Product Development Inc (Director · May 18, 2011 – Dec 5, 2011 · Past); Icos Corp (Director · May 11, 2006 – Jan 29, 2007 · Past); Atherogenics Inc (Director · Apr 26, 2006 – May 22, 2008 · Past) | Director · Dec 31, 2005 – Apr 17, 2007 · Past |
| Christian Weyer Other companies: Intercept Pharmaceuticals Inc (EVP, Research & Development · Nov 27, 2017 – Apr 1, 2021 · Past); Fate Therapeutics, Inc. (See Remarks, Director · Sep 30, 2013 – Apr 13, 2015 · Past) | SVP, Research & Development · Jun 1, 2010 – Feb 22, 2012 · Past |
| James R Gavin III Other companies: Baxalta Inc (Director · Jul 1, 2015 – Jun 3, 2016 · Past); Baxter International Inc. (Director · Apr 19, 2010 – Sep 11, 2020 · Past) | Director · Apr 5, 2010 – Aug 8, 2012 · Past |
| Lloyd A Rowland Other companies: CytomX Therapeutics, Inc. (General Counsel · Jun 13, 2018 – Mar 18, 2025 · Past); Xencor, Inc. (Sr. V.P. and General Counsel · Aug 29, 2014 – Jan 26, 2016 · Past) | VP, Chief Compliance Officer · Dec 30, 2005 – Aug 8, 2012 · Past |
| James N. Wilson Other companies: Corcept Therapeutics Incorporated (CHAIRMAN OF THE BOARD · Since at least Nov 11, 2008) | Director · Oct 3, 2008 – Apr 3, 2009 · Past |
| Marcea Bland Lloyd Other companies: Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past) | SVP, Chief Administrative Offi · Mar 1, 2011 – Feb 8, 2012 · Past |
| Terrance H Gregg Other companies: DexCom, Inc. (Former Executive Chairman, Director · Jan 3, 2006 – Jul 30, 2018 · Past) | Director · Dec 31, 2005 – Apr 5, 2006 · Past |
| Thomas R Testman Other companies: Endocare Inc (Director · Jan 10, 2006 – May 15, 2009 · Past) | Director · Dec 31, 2005 – Jun 1, 2007 · Past |
| Orville G Kolterman | SVP, Chief Medical Officer · Feb 3, 2009 – Feb 22, 2012 · Past |
Log in to ask 6ix AI your own questions about Amylin Pharmaceuticals LLC.